These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
454 related items for PubMed ID: 16481822
1. Osteonecrosis of the mandible or maxilla associated with the use of new generation bisphosphonates. Farrugia MC, Summerlin DJ, Krowiak E, Huntley T, Freeman S, Borrowdale R, Tomich C. Laryngoscope; 2006 Jan; 116(1):115-20. PubMed ID: 16481822 [Abstract] [Full Text] [Related]
4. Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy. Migliorati CA, Schubert MM, Peterson DE, Seneda LM. Cancer; 2005 Jul 01; 104(1):83-93. PubMed ID: 15929121 [Abstract] [Full Text] [Related]
5. Bisphosphonate-associated osteonecrosis: a clinician's reference to patient management. Grewal VS, Fayans EP. Todays FDA; 2008 Aug 01; 20(8):38-41, 43-6. PubMed ID: 18767452 [Abstract] [Full Text] [Related]
8. The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws. Carlson ER, Basile JD. J Oral Maxillofac Surg; 2009 May 01; 67(5 Suppl):85-95. PubMed ID: 19371819 [Abstract] [Full Text] [Related]
9. Bisphosphonate-induced osteonecrosis of the jaw. Krueger CD, West PM, Sargent M, Lodolce AE, Pickard AS. Ann Pharmacother; 2007 Feb 01; 41(2):276-84. PubMed ID: 17299010 [Abstract] [Full Text] [Related]
10. Osteonecrosis of the maxilla and mandible in patients with advanced cancer treated with bisphosphonate therapy. Estilo CL, Van Poznak CH, Wiliams T, Bohle GC, Lwin PT, Zhou Q, Riedel ER, Carlson DL, Schoder H, Farooki A, Fornier M, Halpern JL, Tunick SJ, Huryn JM. Oncologist; 2008 Aug 01; 13(8):911-20. PubMed ID: 18695259 [Abstract] [Full Text] [Related]